Company profile for SGS Life Sciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

SGS Life Sciences is the premier global CRO providing clinical research, analytical development, biologics characterization, biosafety, and quality control testing. Operating 21 facilities in 11 countries, SGS represents the broadest, wholly-owned, global network of contract analytical laboratories. We deliver complete lifecycle solutions for pharmaceutical, biologics, and medical device manufacturers. SGS provides GMP/GLP con...
SGS Life Sciences is the premier global CRO providing clinical research, analytical development, biologics characterization, biosafety, and quality control testing. Operating 21 facilities in 11 countries, SGS represents the broadest, wholly-owned, global network of contract analytical laboratories. We deliver complete lifecycle solutions for pharmaceutical, biologics, and medical device manufacturers. SGS provides GMP/GLP contract laboratory services that include analytical chemistry, microbiology, stability, bioanalysis, extractables/leachables, virology, cell bank and virus seeds characterization, and protein analysis.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
201 Route 17 North, 7th and 8th Floors, Rutherford, New Jersey, 07070
Telephone
Telephone
+1 201 508 3000
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.contractpharma.com/contents/view_breaking-news/2024-07-03/sgs-adds-new-capacity-capabilities-to-bolster-biologics-testing-services/9769

CONTRACT PHARMA
03 Jul 2024

https://www.sgs.com/en-us/news/2022/11/safeguards-13422-eu-general-court-annuls-classification-of-titanium-dioxide-as-carcinogenic

PRESS RELEASE
29 Nov 2022

https://www.sgs.com/en-us/news/2022/11/sgs-recognized-again-as-a-sustainability-leader-by-msci

PRESS RELEASE
28 Nov 2022

https://www.sgs.com/en-us/news/2022/11/safeguards-13322-eu-sets-limit-for-hexachlorobenzene-under-regulation-on-pop

PRESS RELEASE
24 Nov 2022

https://www.sgs.com/en-us/news/2022/11/uk-government-extends-the-deadline-for-applying-the-ukca-mark-to-manufactured-goods

PRESS RELEASE
17 Nov 2022

https://www.sgs.com/en-us/news/2022/11/sgs-issues-its-first-medical-device-regulation-mdr-2017-745-certificate-in-asia

PRESS RELEASE
14 Nov 2022

Services

Upload your portfolio for free, ask us

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty